A simple and accurate fluorimetric procedure for measuring cefuroxime in body fluids is described. A fluorescent product was produced by addition of hydrochloric acid, heating, and cooling, followed by addition of sodium hydroxide and further heating at 1000C. The fluorescence intensity of the final solution was measured in a fluorimeter at an excitation wavelength of 375 nm and an emission wavelength of 440 nm and related to the antibiotic concentration. Thin-layer chromatography of the final solution showed a single fluorescent spot (Rf value, 0.6). Freedom from interference from other therapeutic agents and endogenous substances, as well as the close correlation between this method and the standard microbiological assay method, was demonstrated. The simplicity and reliability of the fluorimetric assay method make it particularly suitable for clinical use.
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Cefuroxime is a new cephalosporin with enhanced f6-lactamase resistance (7, (11) (12) (13) . Microbiological methods for estimating cefuroxime in body fluids have been reported (9, 10) and have been applied in various pharmacokinetic and bioavailability studies (6, 9) . Fluorimetric procedures for other cephalosporins and cefoxitin, a cephamycin antibiotic, have been developed (1-5, 8, 15 ) and applied to various body fluids. These methods are rapid, sensitive, and accurate.
The purpose of this study was to develop a fluorimetric method for estimating cefuroxime in body fluids and to compare it with the standard microbiological method. The separation of the fluorescent product by using thin-layer chromatography is also reported.
MATERIALS AND MErHODS
Cefuroxime sodium was supplied by Glaxo Laboratories. Hydrochloric acid (HCl), sodium hydroxide (NaOH), and trichloroacetic acid were obtained from British Drug House Ltd.
Standard solutions of cefuroxime were prepared in distilled water and on urine and pooled human serum collected from healthy volunteers. The concentration ranges in the respective fluids were 0.1 to 128, 10 to 12,800, and 0.25 to 160 jg/ml. The same water, urine, and serum samples were used as controls.
Fluorescence intensity was measured in an AmincoBowman (SPF) spectrophotofluorimeter equipped with a Xenon lamp.
Optimdztion of assay conditions. Optimization of conditions for the fluorimetric assay of cefuroxime was achieved by applying various concentrations and volumes of NaOH (0 to 2 ml volume of 0.1 to 6 N concentration) before, after, and without treatment of the sample with various concentrations and volumes of HCI (0 to 2 nil volume of 0.1 to 3 N concentration) and heating to different temperatures for various times at every stage of the procedure (room temperature, 22 to 100°C for 0 to 180 min). The pH of the solution was checked after each combination of conditions. Procedure for aqueous solution. A 1.0-ml sample and 1.0 ml of 0.5 N HCI were placed in a long glass tube (15 by 1 cm) which was covered with a stainless steel cap to minimize evaporation. The mixture was heated in a boiling water bath (1000C) for 15 min. After the mixture was cooled under tap water, 1.0 ml of 1.25 N NaOH was added. The mixture was blended on a Vortex mixer, reheated in a water bath (1000C) for 75 min, cooled under tap water and transferred to cuvettes. Fluorescence intensity was measured in a fluorimeter at an excitation wavelength of 375 nm and an emission wavelength of 440 nm.
Procedure for urine. Undiluted control urine gave high fluorescence intensity. Dilutions of 1:10, 1:20, 1: 50, and 1:100 were tested, and 1:100 was found to be the most acceptable.
After a 1:100 (vol/vol) dilution in distilled water, 1.0 ml of the diluted urine was treated as was the aqueous solution. Ptrocedure for serum. Protein precipitation was effected by addition of 1.0 ml of 10% (wt/vol) trichloroacetic acid to an equal volume of serum; the mixture was then blended on a Vortex mixer and centrifuged at 3,000 rpm for 10 min. One milliliter of the proteinfree supernatant was removed and treated as outlined for the aqueous solution.
Separation of the fluorescent product. Two-dimensional thin-layer chromatography was applied using aluminium sheet Silica Gel 60 without fluorescent indicator (E. Merck AG, Darmstadt, Germany). The sheet was developed in chloroform-acetone-acetic acid-methanol (50:50:7:7) for 2 h for each dimension and visualized under long ultraviolet (300 to 360 nm) light.
Microbiological assay. The microbiological dif- The minimum detectable concentrations of cefuroxime were 0.1 jig/ml for aqueous solution, Comparison of the microbiological (x axis) versus the fluorimetric assay (y axis) of urine samples for cefuroxime content shows that the computed regression line is: 1.0123x + 20.61, r = 0.99. The paired t-test indicated no significant difference between the fluorimetric and microbiological assay at P = 0.10.
There was a close correlation between the results of the fluorimetric and microbiological assays of samples from the pharmacokinetic study (Table 1) .
Apart from aspirin, there was no interference with the cefuroxime assay by any of the therapeutic agents and endogenous substances tested (Table 4) .
DISCUSSION
The minimum detectable concentration of cefuroxime in aqueous solution was 0.1 ,g/ml, which is comparable to that obtained with the microbiological assay method with the sensitive B. subtilis MB 32 SDR.
Antibiotic-free urine samples gave a relatively high fluorescence intensity compared with control aqueous solutions and serum. A dilution of 1:100 (vol/vol) was required to minimize this high fluorescence intensity. This gave a low fluorescence intensity slightly higher than that of aqueous solution but lower than that of deproteinized serum. This dilution procedure also re- The miniimum detectable concentration of cefuroxime in urine was 10 Ag/ml. This concentration is much lower than the concentration of the antibiotic in urine obtained 8 h after the administration of therapeutic doses (6) . The background fluorescence of serum was higher than that of aqueous solutions and urine, probably due to persistence of serum components not precipitated by trichloroacetic acid and removed by centrifugation. The sensitivity of the fluorimetric method for cefuroxime in serum was 0.25 ,ug/ml, which is comparable to that obtained by the microbiological assay method.
By applying two-dimensional thin-layer chromatography of the final solution, a single spot with an Rf value of 0.6 in both dimensions was obtained, indicating the presence of one fluorescent product.
The single fluorescent spot was achieved only after applying the optimum conditions to the sample, whereas in the absence of HCI a fluorescent line was observed, indicating incomplete separation of the product.
The results of the linear regression analysis and the paired t-test showed a close correlation between the results of the microbiological and the fluorimetric assay methods. These results, as well as those of the comparative study in the volunteers, demonstrate the accuracy and reliability of the fluorimetric assay method. The fluorimetric assay method is free from interference from all substances studied, except for aspirin. As this method is not affected by the presence of other known antimicrobial agents likely to be given therapeutically in combination, it has substantial advantage over nonspecific microbiological assays.
Therefore, this fluorimetric assay for cefuroxime provides an accurate and simple method of determining the antibiotic levels in serum and urine and could be applied in clinical laboratories.
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